Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
J Pharm Sci. 2010 Mar;99(3):1107-22. doi: 10.1002/jps.21916.
The significance of plasma protein binding on drug efficacy and, subsequently, the clinical relevance of changes in protein binding has been controversially discussed for decades. The uncertainty concerning the impact of plasma protein binding on a drug's pharmacological activity is, in part, related to the approach used when investigating and interpreting protein binding effects in vitro and in vivo. Frequently, a generalized one-size-fits-all approach, such as "protein binding does matter/does not matter," may not be applicable. An appropriate analysis requires careful consideration of both pharmacokinetic and pharmacodynamic processes, as they both contribute to the safety and efficacy of drugs. Therefore, the aim of this article is to provide a concise review of the theoretical concepts of protein binding, and to discuss relevant examples where applicable.
几十年来,关于血浆蛋白结合对药物疗效的意义,以及蛋白结合变化的临床相关性一直存在争议。对于血浆蛋白结合对药物药理活性的影响,人们的不确定性部分源于在体外和体内研究和解释蛋白结合效应时所采用的方法。通常,一种通用的“一刀切”方法(例如“蛋白结合很重要/不重要”)可能并不适用。适当的分析需要仔细考虑药代动力学和药效学过程,因为它们都有助于药物的安全性和疗效。因此,本文的目的是简要回顾蛋白结合的理论概念,并在适用的情况下讨论相关示例。